Unfortunately, we did not obtain detailed information about the treatment protocols for our recruited CRC patients, and thus it is worthy to further investigate whether MAOB can be a predictive biomarker for a specific treatment in CRC. The gene discussed is MAOB; the disease is colorectal carcinoma.